logo

AGEN

AgenusยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

AGEN Profile

Agenus Inc.

An immuno-oncology company with a broad pipeline targeting cancer and infectious disease

Biological Technology
--
02/04/2000
NASDAQ Stock Exchange
316
12-31
Common stock
3 Forbes Road, Lexington, Massachusetts 02421
--
Agenus Inc., founded in 1994, is a Delaware limited liability company. The company is a clinical-stage biotechnology company specializing in the development of therapies that activate the human immune system to fight cancer and infection.